摘要
目的了解胰岛素泵对胰岛β细胞功能的影响。方法对新诊断51例2型糖尿病(T2DM)患者FBG≥15 mmol/L者,分别行胰岛素强化治疗和口服降糖药治疗,观察其血清C-肽浓度的变化。结果强化组治疗4天血糖达标后血清C-肽曲线下面积无明显变化,继续皮下注射胰岛素治疗半年后明显升高(P<0.001)。口服降糖药组亦有改善(P<0.01)。但半年后两组结果显示:应用胰岛素组优于口服降糖药组(P<0.001)。结论胰岛素泵数日快速控制严重高血糖不能消除高血糖毒性对胰岛β细胞功能的抑制,对新诊断的FBG≥14 mmol/L的T2DM患者胰岛素治疗应该持续数月以期改善胰岛功能。
Objective To investigate the influence of insulin pump on type 2 diabetes mellitus. Methods 51 patients were randomized into two groups: 31 cases controlled with insulin pump, 20 treated with oral antidiabetic drugs. Serum level of C-peptide concentration was observed. Results There was a markedly increase in C peptide level in both insulin treating group (P〈0. 001) and oral drug group (P〈0.01), Half an year later, the insulin group was improved in β-cell function better than oral drug group. Conclusions Several days controlling of severe hyperglycemia with insulin pump could not eliminate the β-cell inhibition of glucose toxicity. Newly diagnosed severe type 2 diabe tes (FPG≥14 mmol/L) could be treated with insulin for several months.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2006年第6期446-447,共2页
Chinese Journal of Diabetes
关键词
胰岛素泵
糖尿病
2型
高血糖
C肽
胰岛Β细胞
Insulin pump, Diabetes mellitus, type 2
Hyperglycemia
C-peptide
β-cell